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discovery and lead optimization. In this study we analysed using surface plasmon resonance (SPR) the
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the enthalpic and entropic components of the TS energy barriers for the binding and unbinding events. To
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corresponding to the highest energy barrier the ligand is required to overcome to reach the final state. For
the six ligands evaluated in this study their TS thermodynamic properties were linked in particular to the
role of water molecules in solvating/desolvating the pocket and the small molecules. suMetaD identified
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Abstract
Ligand–protein binding kinetic rates are growing in importance as parameters to consider in drug discovery and lead opti-
mization. In this study we analysed using surface plasmon resonance (SPR) the transition state (TS) properties of a set of 
six adenosine  A2A receptor inhibitors, belonging to both the xanthine and the triazolo-triazine scafolds. SPR highlighted 
interesting diferences among the ligands in the enthalpic and entropic components of the TS energy barriers for the binding 
and unbinding events. To better understand at a molecular level these diferences, we developed suMetaD, a novel molecu-
lar dynamics (MD)—based approach combining supervised MD and metadynamics. This method allows simulation of the 
ligand unbinding and binding events. It also provides the system conformation corresponding to the highest energy barrier 
the ligand is required to overcome to reach the inal state. For the six ligands evaluated in this study their TS thermodynamic 
properties were linked in particular to the role of water molecules in solvating/desolvating the pocket and the small molecules. 
suMetaD identiied kinetic bottleneck conformations near the bound state position or in the vestibule area. In the irst case 
the barrier is mainly enthalpic, requiring the breaking of strong interactions with the protein. In the vestibule TS location 
the kinetic bottleneck is instead mainly of entropic nature, linked to the solvent behaviour.
Keywords Metadynamics · Supervised molecular dynamics · Ligand binding kinetics · SPR · Biacore · Molecular 
dynamics
Introduction
The importance of the pharmacology of adenosine receptors 
(ARs) is daily experienced by millions of cofee drinkers 
worldwide. Indeed, it is well established that cafeine is able 
to non-selectively inhibit AR subtypes (Rivera-Oliver and 
Díaz-Ríos 2014)  (A1,  A2A,  A2B and  A3) leading to a range of 
diferent biological responses and suggesting the potential 
usefulness of AR agonists or blocking agents (Jacobson and 
Gao 2006; Polosa and Blackburn 2009; Stone et al. 2009). 
Increasing attention is being addressed to the  A2A AR and 
its modulation due to its emerging value in multiple disease 
states: Parkinson’s disease (Richardson et al. 1997), mainly 
attributed to the heterodimerization with the dopamine 
receptor  D2 in the central nervous system (CNS) striatum 
(Fink et al. 1992), attention deicit hyperactivity disorder 
(ADHD) and immuno-oncology. The  A2A AR represents a 
good starting point for structure-based drug design (SBDD) 
among all the G protein-coupled receptors (GPCRs) super-
family members. Despite the intrinsic diiculties of GPCR 
crystallography (Ghosh et al. 2015), to date 20 X-ray struc-
tures of the  A2A AR have already been published, in complex 
with both agonists (Lebon et al. 2011, 2015; Xu et al. 2011), 
including a recent structure bound to an engineered G pro-
tein (Carpenter et al. 2016), and antagonists (Congreve et al. 
2012; Doré et al. 2011; Hino et al. 2012; Jaakola et al. 2008; 
Liu et al. 2012; Segala et al. 2016).
Electronic supplementary material The online version of this 
article (https://doi.org/10.1007/s40203-017-0037-x) contains 
supplementary material, which is available to authorized users.
 * Francesca Delorian 
 francesca.delorian@heptares.com
1 Molecular Modeling Section (MMS), Department 
of Pharmaceutical and Pharmacological Sciences, University 
of Padova, Via Marzolo 5, Padua, Italy
2 Heptares Therapeutics Ltd., BioPark, Broadwater Road, 
Welwyn Garden City, Herts AL7 3AX, UK
3 Department of Chemical and Pharmaceutical Sciences, 
University of Trieste, Piazzale Europa, 34127 Trieste, Italy
AQ1
AQ2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
A1
A2
A3
A4
A5
A6
A7
A8
A9
A10
A11
A12
A
u
th
o
r
 P
r
o
o
f
U
N
C
O
R
R
E
C
T
E
D
 P
R
O
O
F
Journal : Large 40203 Article No : 37 Pages : 13 MS Code : INSP-D-17-00022 Dispatch : 16-11-2017
 In Silico Pharmacology _#####################_
1 3
_####_ Page 2 of 13
Compared to the thermodynamic dissociation constant 
 KD, binding kinetic rate constants kon and koff, are gaining 
in importance as parameters to consider in drug discovery 
and lead optimization. In fact, data obtained from in vitro 
steady state conditions are not always predictive for the 
in vivo biological environment, where the concentration of 
a ligand in proximity of its endogenous target is governed 
by pharmacokinetics (PK). As a consequence, increasing 
eforts are being addressed to the development of reliable 
structure-kinetic relationships (SKR), able to drive improve-
ments in the kinetic proile of potential drug candidates. 
Indeed, compounds from a chemical series may show very 
similar ainities but dissimilar kinetic behaviour (Guo et al. 
2017). The dynamic properties of binding equilibria allow 
the thermodynamic constant  KD to be related to the kinetic 
rate constants kon and koff, as shown in Eq. (1)
Drug-like compounds have kon values generally in the 
range of  103–109 M−1 s−1 (the latter is approximately the 
rate limit of free difusion in solution), with koff values rang-
ing from about  10−7 s−1 to approximately 1 s−1 (Copeland 
2015). Interestingly, super-fast binders (e.g. characterized by 
kon larger than  10
9  M−1s−1) have been evolutionary selected 
as efectors of physiologic processes that need instant regu-
lation, like acetylcholine on acetylcholinesterase (AChE) 
(Radić et al. 1997) in the central nervous system (CNS). 
Nowadays it is common to refer to the kinetic concept of 
residence time (tr), irst introduced in 2006 (Copeland et al. 
2006) and deined as the reciprocal of the koff value (e.g. 
tr = 1/koff); tr is related to the in vivo biological efects trig-
gered by ligands (Copeland 2015; Hothersall et al. 2016). 
The value of tr, especially when longer than the pharma-
cokinetic elimination lifetime, is generally associated with 
a favourable pharmacodynamic proile (Dahl and Akerud 
2013) and may be important for tuning the agonist signal-
ling bias (Kenakin and Christopoulos 2012), an emerging 
concept in GPCRs pharmacology. It is deined as the ability 
of ligands to preferentially signal through diferent efec-
tors, triggering a distinct functional efect. Nevertheless, it is 
necessary to consider that also adverse efects can be linked 
to high tr values (Vauquelin et al. 2012). The kon has a cru-
cial role in the setup of protocols for binding measurements 
(Hulme and Trevethick 2010), being the kinetic on rate of 
ligands involved in the experimental procedures; it critically 
drives the time needed to achieve the required equilibrium 
conditions.
From a mechanistic point of view, there is a range of 
driving forces that determine the free energy change dur-
ing molecular binding and unbinding transitions. These 
include desolvation phenomena (Dror et al. 2011; Pan et al. 
2013), conformational entropy loss (Frederick et al. 2007) 
and favourable and unfavourable intermolecular interac-
tions (Radić et al. 1997; Schmidtke et al. 2011). The irst 
extracellular vestibules that ligands encounter are the extra-
cellular loops (ELs), excluding ligands able to reach the 
GPCR orthosteric binding site by difusing from the mem-
brane bilayer [as described by Stanley et al. (2016)]. These 
structural elements can modulate kinetic rates (Guo et al. 
2017; Segala et al. 2016) and selectivity proiles (Nguyen 
et al. 2016; Seibt et al. 2013), mainly due to their intrin-
sic flexibility and high degree of structural variability. 
Molecular dynamics (MD) simulations represent the best 
computational approach for modeling events that are deeply 
inluenced by lexibility and water molecules. Indeed, MD—
based “enhanced sampling” methods are extensively used 
to simulate transitions of chemical systems between energy 
minima that are separated by high energy barriers and there-
fore associated with slow kinetic rates. This is the case for 
ligand unbinding, where the time scale reaches up to several 
hours or days, and is thus too computationally expensive for 
a single unbiased MD simulation starting from the ligand 
bound conformation; nowadays it is possible to reach the 
millisecond time scale on specialized machines (Shaw et al. 
2009). Kinetic descriptions of binding and unbinding have 
been addressed by several diferent approaches, includ-
ing, but not limited to, methods introducing an energy bias 
as a scalar in the potential energy equation of the system 
(Fukunishi et al. 2002; Hamelberg et al. 2004; Luitz and 
Zacharias 2014; Mollica et al. 2015, 2016; Pierce et al. 2012; 
Sinko et al. 2013; Wang et al. 2013) and methods requir-
ing a preliminary deinition of a set of collective variables 
(CVs) to be biased during the simulation (Barducci et al. 
2011; Bui et al. 2003; Gervasio et al. 2005; Guo et al. 2016; 
Isralewitz et al. 2001; Laio and Parrinello 2002; Laio et al. 
2005; Li 2005; Patel et al. 2014; Torrie and Valleau 1977; 
Yu et al. 2016). CVs can be for example intermolecular or 
interatomic distances, angles formed by atoms or group of 
atoms, coordination numbers, degree of solvation and they 
are used in order to drive the binding/unbinding transition 
and to map the corresponding energy proile. Among them, 
metadynamics (Barducci et al. 2011; Gervasio et al. 2005; 
Laio and Parrinello 2002; Laio et al. 2005) is probably one 
of the most used methods. During a metadynamics simula-
tion, a history-dependent energetic term (centred along the 
pre-deined set of CVs) is added at discrete time intervals, 
decreasing the probability that the system will revisit that 
speciic coniguration and increasing the probability of a 
transition from one trough to another one (e.g. the ligand in 
the bound and unbound states, respectively) (Barducci et al. 
2011). More recently, alternative metadynamics approaches 
like adaptive Gaussian (Branduardi et al. 2012) and well 
tempered metadynamics (WT-metaD) (Barducci et al. 2008, 
2011) have been introduced.
(1)KD =
koff
kon
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Computational chemists are constantly working on new 
tools to allow evaluation of ligand kinetics and rational-
ize experimental data. From this perspective, the aMetaD 
protocol (Bortolato et al. 2015) was recently developed and 
tested on three GPCR systems. This approach combines adi-
abatic-bias molecular dynamics (ABMD) (Marchi and Bal-
lone 1999) and WT-metaD in order to simulate ligand–pro-
tein unbinding events and provide an energy estimation of 
predicted transition states. The output from aMetaD allows 
rapid ranking of structurally related ligands according to 
predicted unbinding energetics (e.g. slow of and fast of 
compounds), as well as insights into the water dynamics dur-
ing the dissociation. However, the need for a more complete 
ligand kinetics evaluation inspired us to develop a new pro-
tocol, capable of reconstructing an energy proile associated 
to both the binding and unbinding events: starting from a 
docked intermolecular complex. This MD—based sampling 
method is able to consecutively simulate ligand unbinding 
and binding, using a supervised MD (SuMD) approach 
(Cuzzolin et al. 2016; Sabbadin and Moro 2014) and keep-
ing track of the energy required for the transition by mean 
of metadynamics. The supervised metadynamics (suMetaD) 
algorithm was tested on a set of  A2A AR antagonists (Fig. 1), 
belonging to both the xanthine (XAC, DPCPX, KW3902) 
and the [1,2,4]triazolo[1,5-a][1,3,5]triazine [ZM241385, 
Z48 (Federico et al. 2011), Z80 (Federico et al. 2016)] scaf-
folds, whose transition state thermodynamics were experi-
mentally determined using the surface plasmon resonance 
(SPR) technique (Fig. 2). The past 10 years have seen a sig-
niicant surge in the application of SPR technology to study 
small molecule interactions; it uses a protein in real time 
without labelling (Du et al. 2016; Rich and Myszka 2009). 
Engineering stabilized GPCRs allows SPR techniques to be 
applied to this class of membrane receptors with promis-
ing results (Rich et al. 2011; Shepherd et al. 2014). Using 
Fig. 1  Chemical structures of the  A2A AR ligands considered for the 
suMetaD test. ZM241385, Z80 and Z48 are [1,2,4]triazolo[1,5-a]
[1,3,5]triazine inhibitors; DPCPX, KW3902 and XAC are xanthine 
inhibitors
Fig. 2  Eyring equation plots for the ligand binding association (left) 
and dissociation (right) from the SPR analysis for the 6 ligands 
included in this study. The values for ΔH‡ and ΔS‡ can be determined 
from kinetic data plotting ln(t/T) vs 1/T. In the resulting linear inter-
polation equation the slope corresponds to ΔH‡/R and the ΔS‡ can be 
calculated from the y-intercept
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SPR to measure the ainity of interaction KD at a series of 
temperatures allows the enthalpy ΔH° and entropy ΔS° of 
interaction to be calculated using the van’t Hof equation 
(here in its integrated form)
where R is the universal gas constant. This approach has 
been used in a number of studies (Borea et al. 2004; Roos 
et al. 1998; Sahlan et al. 2010).
Likewise, measuring the rate constant k of association 
or dissociation as a function of temperature enables a crude 
approximation of the enthalpy ΔH°‡ and entropy ΔS°‡ of the 
transition state formation using the Eyring equation (here in 
its integrated form) to be obtained.
where R is the universal gas constant, kB is Boltzmann con-
stant, and h is Planck’s constant.
Studying the mechanism of transition state formation can 
provide important additional information helping to under-
stand why interactions with similar ainities can have dif-
ferent kinetics.
From this standpoint, the suMetaD computational proto-
col allows to obtain insights into kinetic bottlenecks along 
the simulated pathways that ofer a rationale for understand-
ing experimental transition state (TS) thermodynamic data 
and allow generation of working hypotheses on the role of 
enthalpy and entropy during the binding and unbinding rate 
limiting steps.
Using SPR we evaluated the ligand binding and unbind-
ing event to the  A2A AR stabilized receptor (StaR™) for the 
6 ligands shown in Fig. 1. Transition state thermodynam-
ics was evaluated using association and dissociation rate 
constants measured at temperatures between 5 and 35 °C at 
5 °C intervals. A series of ive twofold dilutions of the test 
compounds was injected and the obtained sensorgrams were 
itted to a 1:1 interaction model to obtain the rate constants. 
The temperature dependence of the rate constants was itted 
lnK
D
= ΔH◦∕RT − ΔS◦∕R,
ln
k
T
= −ΔH
◦‡∕RT + ΔS
◦‡∕R + ln k
B
∕h,
to Eyring equation using Biacore T200 evaluation software 
to obtain enthalpy and entropy of TS formation (Fig. 2).
Results
The obtained experimental transition state thermodynam-
ics results are summarized in Table 1. It is interesting to 
note that the spread in the TS free energy for the test set is 
about 2.5 kcal/mol for both the association and dissocia-
tion events. The enthalpic and entropic components however 
have stark diferences in the energy barriers: ΔH and TΔS 
cover a range of more than 20 kcal/mol for the binding event 
and more than 30 kcal/mol for the unbinding event. The 
smaller changes in ΔG‡ among the ligands is the result of 
enthalpy–entropy compensation efects: higher ΔH‡ energy 
barrier correspond to lower − TΔS‡ and vice versa.
To support the analysis of the experimental data we 
developed a novel computational protocol based on MD to 
study putative ligand unbinding and binding events. It is 
based on a supervised algorithm (Sabbadin and Moro 2014), 
that drives the exploration only of ligand–protein conforma-
tions starting from a provided bound state conformation (SI 
Fig. 2) that are compatible with paths linking the orthos-
teric site to the extracellular bulk solvent. It evaluates if the 
ligand is moving in the right direction, calculating the root 
mean square deviation (RMSD) of the ligand coordinates 
during the MD from the unbound (unbinding path) or bound 
(binding path) ligand target conformation. At the same time 
the relative free energy of the unbinding/binding paths are 
estimated using metadynamics (Barducci et al. 2011). Dur-
ing the metadynamics simulation a history dependent bias 
is added to the potential energy landscape representing the 
unbinding and binding events. The analysis of the resulting 
energy proile (SI Fig. 3) allows the estimation of a repre-
sentative protein–ligand conformation corresponding to the 
highest energy barrier the ligand has to overcome during 
its path toward the target positions. These conformations 
can be useful to understand at a molecular level the on and 
off rate TS energy barriers linked to the ligand binding/
Table 1  Transition state 
thermodynamic results obtained 
from the SPR analysis of the 
association and dissociation of 
the six ligands considered in 
this study to the  A2A AR
Association and dissociation rate constants were measured at temperatures between 5 and 35 °C at 5 °C 
intervals
Association (kcal/mol) Dissociation (kcal/mol)
ΔH‡ − TΔS‡ ΔG‡ ΔH‡ − TΔS‡ ΔG‡
ZM241385 19.1 ± 2.2 − 11.2 ± 2.2 7.9 40.6 ± 2.2 − 19.8 ± 2.2 20.8
XAC 10.5 ± 1.7 − 1.5 ± 1.7 9.0 16.7 ± 1.4 2.4 ± 1.4 19.1
DPCPX − 0.4 ± 1.0 10.0 ± 1.0 9.6 8.4 ± 0.9 11.0 ± 0.9 19.4
KW3902 12.2 ± 2.4 − 2.2 ± 2.4 10.0 11.2 ± 2.3 7.7 ± 2.3 18.9
Z80 22.7 ± 1.8 − 12.4 ± 1.8 10.3 19.6 ± 1.8 − 1.4 ± 1.8 18.2
Z48 5.5 ± 1.4 3.6 ± 1.4 9.1 16.5 ± 2.5 2.3 ± 2.5 18.8
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unbinding kinetic bottlenecks. Movies with the simulations 
of the unbinding/binding event for each ligand are available 
as Supplementary Material (videos S1–S6).
Visual inspection of the representative kinetic bottlenecks 
shows diferent location of the ligands in the predicted TS 
complex conformation (Figs. 3, 4). During the binding event 
the ligand faces ordered water molecules in the orthosteric 
site, some creating stable favourable interactions with the 
protein (Fig. 3). When the energy barrier is predicted to be 
located near the vestibule region of the receptor, the ligand 
generally does not need to displace tightly protein-bound 
waters. This is in agreement with the resulting low enthal-
pic energy barrier. In parallel, the solvent is trapped in the 
orthosteric site by the ligand position in the vestibule area, 
resulting in lower probability of exchange with bulk solvent 
and a high entropic barrier to the binding event. For some 
other ligands the energy barrier was predicted to correspond 
to a ligand location deep in the pocket, close to the inal 
bound state. A high enthalpic barrier in this case is expected 
to be linked to the required displacement of water molecules 
in the orthosteric site tightly bounded to the protein. Their 
release to bulk results in a favourable entropic gain linked 
to the ligand binding event.
During the unbinding event the ligand faces a cap of 
ordered water molecules in the orthosteric site and it has to 
disrupt strong protein–ligand interactions (Fig. 4). Similar to 
the analysis of the binding event, we predicted two possible 
ligand locations corresponding to the unbinding transition 
states: near the vestibule region or close to the bound state. 
A kinetic bottleneck near the vestibule area and the extra-
cellular loops is characterized by a high entropic barrier 
mainly linked to the solvation of non-polar ligand atoms. 
In contrast, a low enthalpic barrier is the result of weaker 
interactions with the protein in this region compared to when 
the ligand is located deep in the orthosteric site. An unbind-
ing transition state close to the bound state conformation is 
characterized by a high enthalpic barrier related to strong 
interactions with the receptor. In this case the unbinding 
event starts from a complex conformation where the waters 
are tightly bound to the protein and/or to the small molecule, 
evolving into a nearby TS conformation where they are more 
disordered (resulting in a low entropic energy barrier).
Analysis of the TS thermodynamic properties of ligand 
binding shows a high enthalpic energy barrier for Z80 and 
ZM241385, counterbalanced by favourable entropic gains. 
Visual inspection of the kinetic bottlenecks obtained using 
the suMetaD protocol for these two small molecules (Fig. 5a, 
b) shows ligand positions deep in the orthosteric site. The 
high enthalpic barrier is linked to the displacement of most 
of the water molecules, with stable interactions with the 
protein orthosteric site then created. At the same time their 
release to bulk results in an entropically favourable bind-
ing event. For KW3902 and XAC, the enthalpic TS binding 
energy barriers decrease together with the entropic balanc-
ing efect. This is agreement with their kinetic bottlenecks 
predicted close to the vestibule region (Fig. 5c, d), resulting 
Fig. 3  Schematic overview of the two alternative transition state 
locations detected by the suMetaD protocol for the ligand binding 
event. The ligand is represented by a blue circle, waters by smaller 
red circles, the pocket by a blue line divided by a black dotted line in 
the orthosteric site (bottom half) and the vestibule region (top half). 
Starting from the unbound state (left) with strong protein–water inter-
actions and ordered waters the ligand reaches the bound state (right). 
Two alternative ligand locations corresponding to the transition state 
have been detected, the upper transition state showing the energy bar-
rier is near the vestibule region and the lower one where it is deep in 
the orthosteric site. They are characterized by opposite enthalpic and 
entropic components related to the desolvation of the binding site
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in the release to bulk of only part of the stable waters in the 
site. SPR data shows Z48 binding TS barrier is character-
ized by both enthalpic and entropic components, while for 
DPCPX is only entropic. Visual inspection of their kinetic 
bottlenecks (Fig. 5e, f) shows binding positions in the ves-
tibule region creating weak interactions with the receptor. 
These interactions can explain the low enthalpic component 
of the binding energy. Their location near the loops results 
in a large structured water network in the pocket that needs 
to be disrupted to allow the small molecule to reach the inal 
bound state, causing a higher entropic barrier.
Analysis of the TS thermodynamic properties of ligand 
unbinding shows a high enthalpic energy barrier for 
ZM241385 counterbalanced by a favourable entropic gain. 
The predicted position/conformation (Fig. 6a) for its unbind-
ing kinetic bottleneck shows the ligand still tightly bound in 
the orthosteric site. In this pose it creates good interactions 
with the receptor, linked to the high experimental enthalpic 
barrier. The counterbalancing entropic component can be 
related to the lexible 4-ethylphenol tail sitting on top of 
the binding site and less ordered waters (compared to the 
bound conformation) at the interface between the protein 
and the small molecule. For the other ligands, solvation 
of non-polar hydrophobic saturated ring or aliphatic tails 
results in increasing unbinding entropic energy barriers. In 
Z80, XAC and Z48 transition states (Fig. 6b–d) the water 
network starts to act more like a lid on the extracellular side. 
The solvent molecules create a complex web of hydrogen 
bond interactions hindering ligand unbinding. In KW3902 
(Fig. 6e), the bulky and hydrophobic saturated ring system 
touching the solvent increases further the unbinding entropic 
barrier. The predicted kinetic bottleneck positions for these 
ligands are between the bound state and the loops creating 
interactions with the receptor not as strong as ZM241385 
in its TS position. In particular, the predicted TS pose for 
DPCPX (Fig. 6f) is in the loop region close to several sol-
vent molecules, creating a cage of H-bonds, resulting in a 
high entropic energy barrier for ligand unbinding.
Discussion
It is still challenging to understand ligand binding and 
unbinding kinetic properties at a molecular level. In general, 
transition state energy barriers correspond to kinetic bottle-
neck positions and conformations the ligand needs to over-
come to reach the inal state. Their enthalpic and entropic 
components determine ligand on and off rates. TS enthalpy 
barriers are mainly linked to polar interactions among the 
ligand, the protein and the waters, while the entropic com-
ponent is strongly related to changes in protein/ligand lex-
ibility and solvation/desolvation efects. For the ligands 
considered in this study, the binding entropy barrier was 
found to be correlated to the number of temporary trapped 
Fig. 4  Schematic overview of the two alternative transition state 
locations detected by the suMetaD protocol for the ligand unbind-
ing event. As in Fig.  3, the ligand is represented by a blue circle, 
waters by smaller red circles, the pocket by a blue line divided by a 
black dotted line in the orthosteric site (bottom half) and the vesti-
bule region (top half). Starting from the bound state (left) with strong 
protein–ligand interactions and ordered waters the ligand reaches the 
unbound state (right). Two alternative ligand locations corresponding 
to the transition state have been detected: on the top, the energy bar-
rier is near the vestibule region; on the bottom is deep in the orthos-
teric site. They are characterized by opposite enthalpic and entropic 
components related to the solvation of the binding site and of the 
small molecule
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waters in the orthosteric site in the predicted energy barrier 
position/conformation (Fig. 7). For the unbinding event the 
TS entropic barrier was related to the number of waters in 
the extracellular side of the receptor at less than 4 Å from 
the ligand aliphatic carbon atoms (Fig. 7).
Using a molecular dynamics-based approach we have 
been able to simulate the ligand binding and unbinding 
events to extract possible low energy pathways linking the 
docked ligand location to the extracellular side of the recep-
tor. Using a supervised MD algorithm the simulation explo-
ration is optimized to consider only directions compatible 
with the desired binding or unbinding events. In parallel we 
enhanced the conformational space sampling and we evalu-
ated the energy of the obtained hypothetical pathway using 
metadynamics. Metadynamics allows the extraction of a 
representative conformation of the system corresponding to 
Fig. 5  Protein–ligand locations/conformations corresponding to the 
binding kinetic bottlenecks detected by the suMetaD protocol for the 
6 small molecules considered in this study. The ligand is shown in 
stick representation, the pocket as a mesh surface and waters as small 
spheres. Interactions among waters in the orthosteric site are shown 
as yellow dotted lines. The experimental energy of the enthalpic 
(ΔH‡) and entropic (−TΔS‡) components of the TS is reported
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the high energy barrier the ligand has to overcome to reach 
the target state. The resulting molecular details of the kinetic 
bottlenecks have been useful to generate testable working 
hypothesis to understand the key aspects of the ligand struc-
ture determining the on and off rates.
For the six ligands evaluated in this study their transi-
tion thermodynamic properties were linked in particular to 
the role of water molecules. During the binding event the 
ligand has to face a complex ordered water network in the 
pocket. Its ability to disrupt those interactions, resulting in 
the expulsion of waters into bulk solvent, determines if the 
TS conformation will be near the inal bound state position 
or in the vestibule area, close to the extracellular loops. In 
the irst case the barrier is mainly enthalpic, requiring the 
breaking of stable protein–waters interactions. In the second 
case it will be largely entropic, due to temporarily trapped 
waters in the pocket. These opposite energetic components 
result in the enthalpy–entropy compensation efect we see 
experimentally for the six ligands.
It is possible to reach a similar conclusion from the anal-
ysis of the unbinding events. TS positions/conformations 
can be near the starting bound state position or in the ves-
tibule area. In the former case the barrier is mainly enthal-
pic, requiring the breaking of strong interactions with the 
protein. In the latter case with a vestibule TS location, the 
kinetic bottleneck is instead mainly of an entropic nature, 
linked to the solvation of the ligand and the binding site.
In conclusion, several diferent aspects can play impor-
tant roles afecting the transition state energy barrier that 
the small molecule has to overcome to reach the inal state. 
The suMetaD method we developed and presented in this 
paper provides a useful tool to improve our understanding 
of the TS molecular details. It can help both to interpret 
structure-kinetic relationships and to make predictions for 
new molecules. The promising results obtained for the test 
Fig. 6  Protein–ligand positions/conformations corresponding to the 
unbinding kinetic bottlenecks detected by the suMetaD protocol for 
the 6 small molecules considered in this study. The ligand is shown 
in stick representation, the pocket as solid grey surface and waters 
as small spheres. Interactions among waters in the vestibule region 
near the ligand and among the extracellular loops are shown as yel-
low dotted lines. The experimental energy of the enthalpic (ΔH‡) and 
entropic (−TΔS‡) components of the TS is reported
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set presented herein need now to be extended to a bigger 
transition state thermodynamic datasets to fully prove the 
general applicability of this approach.
Methods
Expression of  A2AR in insect cells
A2A AR StaR 2 carrying a C-terminal deca His tag was 
expressed in Sf21 cells grown in ESF921 medium supple-
mented with 10% (v/v) FBS and 1% (v/v) Penicillin/Strep-
tomycin using the FastBac expression system (Invitrogen). 
Cells were infected at a density of 2.5 × 106 cells/ml with 
baculovirus at an approximate multiplicity of infection of 
1. Cultures were grown at 27 °C and harvested 48 h post 
infection.
Membrane preparation and protein puriication
All subsequent puriication steps were carried out at 4 °C. To 
prepare membranes, 2 l of cells were re-suspended in PBS 
bufer supplemented with cOmplete Protease Inhibitor™ 
tablets (Roche) and 5 mM EDTA. Cells were disrupted by 
micro-luidizer at 60 PSI and membranes collected by ultra-
centrifugation at 204.7 k×g for 1 h. Membranes were washed 
with PBS bufer supplemented with protease inhibitor tablets 
and 500 mM NaCl, collected by ultracentrifugation and re-
suspended in 40 mM HEPES pH 7.5, 250 mM NaCl and 
stored at − 80 °C. Just prior to solubilization membranes 
were thawed, homogenized, supplemented with 10  µM 
ZM24134 and incubated on a roller mixer for 60  min. 
Membranes were solubilized with 1.5% (w/v) DM for 1 h, 
insoluble material was removed by ultra-centrifugation 
and the solubilized lysate batch bound to 5 ml of Ni–NTA 
Superlow resin (Qiagen) for 3 h in the presence of 10 mM 
imidazole. Resin was washed with a gradient of 10–50 mM 
imidazole in 40 mM HEPES pH 7.5, 250 mM NaCl, 0.15% 
(w/v) DM, and 10 µM ZM24134 over 35 column volumes 
before bound material was eluted in a step with 245 mM imi-
dazole. Receptor was further puriied by gel iltration (SEC) 
in 40 mM HEPES pH 7.5, 150 mM NaCl, 0.15% (w/v) DM, 
and 10 µM ZM24134. Receptor purity was analyzed using 
SDS-PAGE and LC–MS, and receptor monodispersity was 
assayed by analytical SEC. Protein concentration was deter-
mined using the receptor’s calculated extinction coeicient 
at 280 nm [ε280, calc = 47,780 (mg/ml × cm)
−1] and con-
irmed by quantitative amino acid analysis.
Assay of binding thermodynamics by SPR
SPR experiments were carried out on a Biacore T200 instru-
ment with a sensor chip NTA (GE Healthcare). The running 
bufer was 10 mM phosphate, pH 7.4, 2.7 mM KCl, 137 mM 
NaCl, 0.05 mM EDTA, 5% DMSO.  A2A AR was injected 
over Ni-loaded chip NTA at 200 nM for 10 min at 10 °C 
to obtain about 5000 resonance units (RU) of immobilised 
receptor. Transition state thermodynamics was evaluated 
using association and dissociation rate constants measured at 
temperatures between 5 and 35 °C at 5 °C intervals. A series 
of ive twofold dilutions of the test compounds was injected 
and the obtained sensorgrams were itted to 1:1 interaction 
model to obtain the rate constants. The temperature depend-
ence of the rate constants was itted to Eyring equation using 
Biacore T200 evaluation software to obtain enthalpy and 
entropy of transition state formation.
suMetaD
For the ligands ZM241385, Z48 and Z80, the  A2A AR con-
formation was based on PDB:4EIY (Liu et al. 2012), while 
for the other ligands PDB:3REY (Doré et al. 2011) was used. 
The fusion protein was removed from 4EIY and the protein 
sequence was modiied to correspond to the construct used 
in the SPR experiments using Prime (Jacobson et al. 2004) 
(Schrödinger Release 2016-3). Receptors were prepared with 
the Protein Preparation Wizard in Maestro (Schrödinger 
Release 2016-3): the H-bond network has been optimized 
through an exhaustive sampling of hydroxyl and thiol moie-
ties, tautomeric and ionic state of His and 180° rotations of 
Fig. 7  Role of the solvent in the transition state entropic energy bar-
rier. The experimental binding (blue) and unbinding (red) TS entropic 
barrier for the 6 ligands considered in this study is plotted on the 
X-axis. The Y-axis shows for the binding event (blue) the correspond-
ing number of temporary trapped waters in the orthosteric site in the 
representative TS conformation. For the unbinding event (red), the 
Y-axis includes the number of waters in the extracellular side of the 
receptor at less than 4 Å from the ligand aliphatic carbon atoms in the 
representative TS conformation
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the terminal dihedral angle of amide groups of Asp and Gln. 
His264 has been considered to be protonated. The starting 
docking poses for Z48 and Z80 were based on ZM241385 
and reined using Glide (Friesner et al. 2004; Halgren et al. 
2004). For Z80 the rotameric state of H264 and E169 were 
modiied to be comparable to the conformation of the cor-
responding residues in the PDB 3PWH (Doré et al. 2011) 
 A2A AR crystal structure. The docking poses of DPCPX 
and KW3902 were based on XAC bound crystallographic 
conformation and reined using Glide (Friesner et al. 2004; 
Halgren et al. 2004). For these two ligands  Y2717.36 rota-
meric state was changed to be comparable to its conforma-
tion in 4EIY.
The supervised metadynamics protocol (included in a 
single python script, suMetaD.py) uses as input the pro-
tein PDB, and the bound conformations of the ligands (as 
SDF) and reasonable target ligand unbound positions near 
the extracellular side (also as SDF), at about 20 Å from the 
bound conformation. aMetaD.py protocol can be divided in 
the two steps: (1) system preparation and equilibration; (2) 
supervised metadynamics (suMetaD).
System preparation and equilibration
Every ligand-receptor complex is aligned to a reference 
(+Z corresponds to the extracellular side, −Z to the intra-
cellular side, the membrane is in the XY plane). The sys-
tem is equilibrated using the following molecular dynam-
ics protocol. The AMBER99SB force ield (f) parameters 
(Lindorf-Larsen et al. 2010) were used for the protein and 
the GAFF f (Wang et al. 2004) for the ligands using AM1-
BCC partial charges (Jakalian et al. 2002). The system has 
been embedded in a triclinic box including an equilibrated 
membrane consisting of 256 DMPC (1,2-dimyristoyl-sn-
glycero-3-phosphocholine) lipids (Jämbeck and Lyubartsev 
2012) and 24,513 waters using g_membed (Wolf et al. 2010) 
in Gromacs. The SPC water model was used and ions were 
added to neutralize the system (inal concentration 0.01 M). 
An energy minimization protocol based on 1000 steps steep-
est-descent algorithm has been applied to the system. The 
membrane has been equilibrated using 0.5 ns MD simula-
tion with a time step of 2.5 fs, using LINCS on all bonds 
and keeping the protein and ligand restrained applying a 
force of 100 kJ mol−1 nm−1. Lennard-Jones and Coulomb 
interactions were treated with a cut-of of 1.069 nm with 
particle-mesh Ewald electrostatics (PME) (Darden et al. 
1993). The MD has been executed in the NPT ensemble 
using v-rescale (Bussi et al. 2007) (tau_t = 0.5 ps) for the 
temperature coupling to maintain the temperature of 298 K 
and using Parrinello–Rahman (Parrinello and Rahman 1981) 
(tau_p = 10.0 ps) for the semi-isotropic pressure coupling 
to maintain the pressure of 1.013 bar. Without applying any 
positional restraints, the system has been minimized for 200 
steps using the steepest-descent algorithm and equilibrated 
using MD using the same settings described above, but with 
a time step of 2 fs and increasing the temperature from 29.8 
to 298 K in 10 steps (9 steps of 30 ps and the last one of 
300 ps).
Supervised metadynamics (suMetaD)
The metadynamics (Barducci et al. 2011) protocol exploits 
a generic path collective variable (CV) (Branduardi et al. 
2007) generated using the RMSD between the starting 
ligand bound state and a ligand position corresponding to 
the original starting ligand location translated 3 Å on the 
X-axis. Two path CVs have been considered: one deining 
the RMSD position on this path (s) and the other the RMSD 
distance from the path (z) using lambda = 20. The same 
MD settings used during the inal system equilibration at 
298 K are used for the suMetaD protocol. For the meta-
dynamics algorithm the following settings have been used: 
initial energy bias Gaussian height of 0.25 kcal/mol with a 
deposition frequency of 1 ps. The width of the Gaussians 
was 0.01 Å. The suMetaD protocol is divided in two con-
secutive parts:
1. The ligand unbinding event is simulated irst using a 
maximum of 200 metadynamics steps of 50 ps each 
(always writing to the same COLVAR ile using the 
RESTART keyword) for a total of maximum 10 ns. The 
supervised algorithm is implemented in the following 
way: after every step if the RMSD from the target ligand 
position is decreased the next step starts from the end of 
the previous step, otherwise from the beginning of the 
previous step assigning new random atom velocities. If 
the ligand reaches a distance of 15 Å from the bound 
position the simulation is stopped.
2. The inal output coordinates from the ligand unbinding 
simulation is used as a starting conformation for ligand 
binding simulation. As before, a maximum of 200 meta-
dynamics steps of 50 ps each are simulated. A compa-
rable supervised algorithm is used, but the RMSD from 
the target bound ligand position is used. If the ligand 
reaches a distance of 3 Å from the bound position the 
simulation is stopped.
The inal results included for the analysis are: (1) the 
binding/unbinding trajectories; (2) the metadynamics energy 
proile as function of the bound state RMSD; (3) the confor-
mation corresponding to the highest energy barrier (based on 
the metadynamics bias energy deposition) for the unbinding 
and binding event.
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